Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. PBH Peers
See (PBH) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PBH | $80.18 | -0.17% | 4B | 18.69 | $4.29 | N/A |
| MCK | $705.45 | -3.06% | 88.3B | 27.42 | $25.74 | +0.40% |
| COR | $291.17 | -1.41% | 56.4B | 33.73 | $8.63 | +0.74% |
| CAH | $161.98 | -1.47% | 38.6B | 25.33 | $6.39 | +1.25% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $74.48 | +0.00% | 9.1B | 23.20 | $3.21 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +1.66% |
| GRDN | $20.59 | -3.79% | 1.3B | -12.95 | -$1.59 | N/A |
| OMI | $9.29 | -1.38% | 711M | -1.95 | -$4.76 | N/A |
| ZYXI | $2.69 | +1.13% | 81.3M | -11.21 | -$0.24 | N/A |
Stock Comparison
PBH vs MCK Comparison
PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PBH stands at 4B. In comparison, MCK has a market cap of 88.3B. Regarding current trading prices, PBH is priced at $80.18, while MCK trades at $705.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PBH currently has a P/E ratio of 18.69, whereas MCK's P/E ratio is 27.42. In terms of profitability, PBH's ROE is +0.12%, compared to MCK's ROE of -1.33%. Regarding short-term risk, PBH is less volatile compared to MCK. This indicates potentially lower risk in terms of short-term price fluctuations for PBH.